Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cenna Biosciences Inc.

Clinical trials sponsored by Cenna Biosciences Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Alzheimer's drug 8M2D enters first human safety trials Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New Alzheimer's drug 8M2D enters first human safety trials

Disease control Not yet recruiting

This early-stage study tests a new drug called 8M2D for the first time in people. The goal is to see if it is safe and tolerable in healthy adults and in people with early Alzheimer's disease. Researchers will also check if 8M2D can lower amyloid beta, a protein linked to Alzheim…

Phase 1 • Sponsor: Cenna Biosciences Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC